The rough mutants of Gram-negative bacteria are widely used to induce protective antisera but the nature of the target epitope for such antibodies is not precisely defined. Endotoxin is one of several antigens present on the surface of bacterial cells, which are able to elicit specific antibodies. We studied the specificity of antibodies produced against a conjugate of E. coli J5 endotoxin core oligosaccharide with tetanus toxoid. The use of chemically defined antigen for immunisation excludes the possibility of production of antibodies against other cell surface antigens. A comparison of this monospecific anti-endotoxin serum with antiserum against E. coli J5 whole cells was performed in order to distinguish the role that endotoxin core oligosaccharide plays in the interaction with humoral host defences from that of other potentially important Gram-negative bacterial surface antigens. 
and by flow cytometry. Both antisera reacted with similar specificity with most lipopolysaccharides of identical or related core type. Less distinct reactions with endotoxins of the antibacterial serum in comparison with the anti-conjugate serum were found in all serological tests. LPS of E. coli O100 that showed the strongest reactions with both sera was used to stimulate IL-6, TNFa and nitric oxide production by the J-774A.1 cell line. Both sera were used to inhibit that stimulation and no inhibitory effects of the examined sera in comparison with non-immune serum were observed.
Lipopolysaccharide (LPS) is the main component of the outer membrane of the cell envelope of Gram-negative bacteria. Lipopolysaccharide is responsible for the initiation of endotoxic shock, therefore this molecule is a target for new preventive and therapeutic strategies. It has been found that endotoxins derived from different bacterial species share common basic structure (Holst et al., 1996) . LPS consists of a polysaccharide part that includes an O-specific chain and core oligosaccharide (OS) covalently linked to lipid A. Most of the antibodies produced during immunisation with bacterial cells are directed against the O-specific part of endotoxin. The variability of O-serotypes among bacteria of one species excludes the use of anti-LPS antibodies as broad-protective candidates for therapeutic intervention in the case of infection. The core oligosaccharide is a conserved part of endotoxins. Structural analysis of lipopolysaccharides isolated from different strains of bacteria show lower variability among the core oligosaccharide parts in comparison with O-specific chains. These findings have prompted investigators to use rough mutants that lack the O-specific polysaccharide in an attempt to induce protective anti-core endotoxin antibodies. Such anti-core antibodies obtained as a result of immunisation with whole cells of rough mutants can recognise core oligosaccharide epitopes in the LPS structure on the surface of bacterial cells.
E. coli J5 is the most frequently studied rough mutant, isolated by Elbein and Heath (Elbein & Heath, 1965; Ziegler et al., 1973) from a parent culture of E. coli serovar O111:B4. E. coli J5 produces LPS that lacks O-specific chain and possesses an incomplete core oligosaccharide of the Rc chemotype (Muller-Loennies et al., 1994; Muller-Loennies et al.,1999) . Numerous experiments have been performed to examine therapeutic properties of antibodies directed against E. coli J5 whole cells during the last three decades. However, the results obtained by different groups were contradictory, regarding the existence of these broadly cross-reactive and cross-protective antibodies and the nature of the target epitope (Hustinx et al., 1997) . Several explanations of the lack of cross-protective activity of antibodies against whole cells of E. coli J5 were proposed. The heterogeneity of E. coli J5 vaccine and protection via anti-OMP (outer membrane proteins) antibodies are the main reasons of such a discrepancy in outcomes reported for cross-protection studies with E. coli J5 antisera. The antigenic and immunogenic differences in LPS of E. coli J5 vaccine strains depend on their origin and on the growth conditions. Some of the examined strains were identical with the original J5 strain and were unable to synthesise LPS with complete core structure substituted with O-specific polysaccharide. Several strains were found to contain LPS of the R3 chemotype while several others expressed complete R3 core structure and O-antigen, as a result of a reversion of the J5 mutant to the smooth form (Appelmelk et al., 1986; Evans et al., 1992; Appelmelk et al., 1993) . It was shown that antiserum against E. coli J5 contains antibodies reactive with OMP of heterogeneous Gram-negative bacteria. These results suggested that some of the in vivo protection described by earlier investigators could be conferred by anti-OMP IgG (Brauner et al., 1986; Hellman et al., 1997; Hellman & Warren, 1999; Hellman et al., 2000) . These findings prompted us to compare the specificity of anti-E. coli J5 antiserum with antibodies obtained against chemically defined E. coli J5 LPS core oligosaccharide conjugated with tetanus toxoid (OS J5-TT).
Several antigens present on the surface of bacteria are able to elicit specific antibodies during immunisation with bacterial cells. We examined the immunogenicity and cross-reactivity of covalent conjugates of core oligosaccharides of E. coli R1, R2, R3, J5 and Salmonella Ra LPSs in our previous study (Lugowski et al., 1996a; 1996b) . The covalent conjugate of E. coli J5 core oligosaccharide with tetanus toxoid is an antigen with defined structure. The use of this conjugate to elicit anti-bacterial serum excludes the possibility of antibodies production against additional cell surface antigens such as OMP, E. coli R3 complete core structures and O-specific chains of E. coli O111:B4 LPS. We obtained and compared rabbit sera against E. coli J5 and the glycoconjugate (OS J5-TT).
This work was carried out in order to get insight into the role that endotoxin core oligosaccharide, a potentially important Gramnegative bacterial surface antigen, plays in the interaction with humoral host defences.
MATERIALS AND METHODS

Bacteria.
The rough mutant strains of E. coli and Salmonella typhimurium were kindly provided by Prof. Helmut Brade (Research Center Borstel, Germany). The strains of Bordetella pertussis were obtained from the Sera and Vaccines Central Research Laboratory (Warsaw, Poland). Plesiomonas shigelloides O54 was obtained from the collection of the National Institute of Public Health (Prague, Czech Republic). Other strains of smooth bacteria were obtained from the collection of the Institute of Immunology and Experimental Therapy (Wroc³aw, Poland). Bacteria were grown in liquid medium, killed with 0.5% phenol and centrifuged using a CEPA flow laboratory centrifuge (Petersson et al., 1997 Lipopolysaccharide and core oligosaccharides. LPS of E. coli J5 was extracted from bacterial cells by the phenol/chloroform/petroleum ether procedure (Galanos et al., 1969) . The yield of LPS was 2% of dry bacterial mass. LPS was degraded by treatment with 1.5% acetic acid at 100°C for 1 h. The reaction mixture was centrifuged to separate lipid A and supernatant was freeze-dried as described earlier (Niedziela et al., 1996) . The water-soluble mixture of oligosaccharides was fractionated on a Bio-Gel P-10 column (1.61 00 cm, equilibrated with 0.05 M pyridine/ acetic acid buffer, pH 5.6) (Petersson et al., 1997) . Eluates were monitored with a Knauer differential refractometer. The mixture of oligosaccharides eluted from Bio-Gel P-10 was separated on a Bio-Gel P-2 column (1.8´90 cm, in the same buffer). Three fractions were eluted, freeze-dried and checked by 1 H NMR and matrix-assisted laser-desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF). Analytical procedures. Sugars were analysed as their alditol acetates by GLC-MS (gas liquid chromatography-mass spectrometry). Methylations were performed according to the method of Hakomori (1964) and methylated sugars were analysed by GLC-MS as pre- Vol. 49 Serological specificity of antibodies directed against E. coli J5 endotoxinviously described (Petersson et al., 1997 to analysis. The data were acquired and processed using standard Bruker software. Preparation of core oligosaccharide conjugate with tetanus toxoid (TT). The conjugation was carried out according to the method of Jennings and Lugowski using reaction of reductive amination (Jennings & Lugowski, 1982) . The core oligosaccharide was oxidised with 0.75% NaIO 4 (1 ml) in darkness at 4°C for 30-45 min. The excess of periodate was destroyed by adding ethylene glycol. After purification on a Sephadex G-25 (2.6´90 cm) column equilibrated with 0.02 M pyridine/CH 3 COOH buffer, pH 5.4, the product was freeze-dried. The oxidised core oligosaccharide of E. coli J5 LPS was dissolved in 0.5 M K 2 HPO 4 , pH 9.0 (1 ml). Tetanus toxoid (3 mg), NaBCNH 3 (10 mg) and one drop of chloroform were added to the solution. The reaction mixture was kept in sealed vials for 12 days at 37°C and then applied to a Sephadex G-100 column (1.6´100 cm) equilibrated with phosphate-buffered saline (PBS), pH 7.5. Fractions containing the conjugate were concentrated by ultrafiltration.
Immunisation procedure. Rabbits were immunised with 50 mg of the conjugate suspended in Freund's complete adjuvant at days 0 and 21 as described (Lugowski et al., 1996b) . The animals were bled 14 days after the second injection. Polyclonal antibodies against the whole bacterial cells of E. coli J5 were obtained by intravenous immunisation of rabbits with freeze-dried bacteria suspended in PBS as described (Lugowski & Romanowska, 1978) .
Microprecipitin test. Quantitative microprecipitin test was carried out by the method of Kabat & Mayer (1967) . The reaction mixture contained in addition 2% polyethylene glycol 6000. SDS/PAGE was carried out by the method of Laemmli (1970) with modifications (Romanowska et al., 1988) and the LPS bands were visualised by silver staining (Tsai & Frasch, 1982) . ELISA and ELISA inhibition test. ELISA was performed by a modification of the method of Voller et al. (1975) as previously described (Lugowski et al., 1996b) .
In the inhibition studies the antiserum (100 ml) at concentration twice as high as that giving A 405 in the range 0.8-1.1 was mixed with 100 ml of inhibitor solution and incubated for 1 h at 37°C. The mixture (100 ml) was transferred into the wells of a microtiter plate coated with E. coli J5 LPS and the reaction was carried out at room temperature for 15 min. The washing of the wells, incubation with second antibody conjugated with alkaline phosphatase and colour development were performed as described earlier (Lugowski et al., 1996b) .
Immunoblotting. Immunoblotting was performed on the SDS/PAGE separated LPS fractions as described earlier (Lugowski et al., 1996a) .
Immunofluorescence procedures. Bacteria were cultured in nutrient broth to logarithmic phase of growth, harvested, washed and suspended in PBS to an A 600 of 0.6 (4´10 8 cfu ml -1 ). Bacteria were mixed with antiserum (0.5 ml, 100 times diluted) and incubated at room temperature for 2 h. Non-immune sera were employed as negative controls. After three-times washing with PBS the bacteria were incubated for 3 h with FITC (fluorescein isothiocyanate)-labelled goat anti-rabbit IgG as a detecting antibody. The bacteria were washed with PBS and suspended in 0.5% paraformaldehyde (Lugowski et al., 1996b) . Fluorescence activated cell sorter analysis. FACS analysis was performed using a FACSscan fluorescence-activated cell sorter (Becton Dickinson; argon-ion laser 488 nm at 14 mW). Twenty-thousand bacteria were evaluated in each analysis. Narrow angle forward light scatter and FITC (green fluorescence) emission signals were collected. Bacterial aggregates were electronically excluded on the basis of light scatter signals (Lugowski et al., 1996b) .
Inhibition of TNFa, IL-6 and NO release in J-774A.1 cells. J-774A.1 cells were plated in 24-well tissue culture plates (Nunc, Denmark) at 1´10 6 cells/well in 1 ml of Dulbecco's medium supplemented with 10% (v/v) FCS, incubated 16 h and washed twice with serum free medium. The lipopolysaccharide isolated from smooth strain of E. coli O100 (10 ng) was used as a stimulant. The cells were incubated in 1 ml of medium with: (A) LPS and anti-OS J5-TT conjugate rabbit serum (100 ml), (B) LPS and anti-E. coli J5 serum (100 ml), (C) LPS and non-immune serum (100 ml) and (D) PBS. The supernatants were collected to determine TNFa (after 4 h), IL-6 (after 24 h) and total concentration of nitrite and nitrate as stable metabolites of NO (after 48 h) and stored at -80°C until determination. TNFa bioassay. TNFa concentration in the supernatants was determined in the cytotoxic assay using the WEHI 164.13 bioassay (Espevik et al., 1986) . Briefly, WEHI 164.13 cells were seeded at a concentration 2´10 4 cells/well in a 96-well plate (Nunc, Denmark). Decreasing dilutions of the assayed supernatants in RPMI 1640 medium (25 ml) were added to the target cells in the presence of actinomycin D (1 mg ml -1 ). After incubation for 20 h, cell viability was determined by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric assay. The concentration of TNFa was expressed as pg ml -1 , using mouse recombinant TNFa (Pharmingen, U.S.A.) as a standard. The detection limit of the WEHI 164.13 cell cytotoxicity assay was approximately 0.15 pg ml -1 .
IL-6 assay. IL-6 activity was determined using the OptEIA TM kit (Pharmingen, U.S.A.).
The test was performed using polystyrene microtiter plates (Maxisorb, Nunc, Denmark) according to the instructions provided. TMB (3,3¢,5,5¢-tetramethylbenzidine) reagent set provided by Pharmingen was used as a substrate for horseradish peroxidase. The absorbance was measured at 450 nm using a Behring EL311s microplate reader. Nitric oxide determination. Total nitrite + nitrate (NO 2 -+ NO 3 -) in the supernatants collected from stimulated J-774A.1 cells was determined by the Griess reaction in 100 ml of the test samples. Nitrate was reduced by nitrate reductase. Briefly, 50 mU (5 ml) of nitrate reductase (EC 1.6.6.2) and 1 ml of NADPH (stock, 0.65 mg in 100 ml) in Tris/HCl buffer, pH 7.5, were added to the tested supernatant (100 ml). The reaction was carried out at 25°C for 30 min, followed by the colorimetric test using Griess reagent. Samples were incubated for 10 min at room temperature with 100 ml of Griess reagent (1% sulfanilamide, 0.1% N-(1-naphthyl)-ethylene-diamine dihydrochloride in 5% H 3 PO 4 ). Absorbance was measured at 540 nm using a Vol. 49 Serological specificity of antibodies directed against E. coli J5 endotoxinBehring EL311s microplate reader. NO 2 -concentrations were calculated by comparison with a standard curve prepared using NaNO 2 (Schmidt, 1995) .
MTT colorimetric assay for cell growth / cell killing. The method was performed according to Mosmann (1983) with a modification (Hansen et al., 1989) . Briefly, MTT (5 mg ml -1 stock solution) was added (25 ml per well)
at the end of the assay and after 3 h of incubation at 37°C in 100% humidity, 100 ml of lysis buffer (20% SDS, 50% dimethylformamide, pH 4.7) was added. After additional overnight incubation, absorbance was measured at 562 nm. Statistical analysis. Assays were performed using triplicate cultures. Data are expressed as means ± standard deviation (± S.D.) and differences between them were analysed using Student's t-test. Differences at P < 0.05 were considered significant.
RESULTS AND DISCUSSION
Structural analysis of the core oligosaccharide
Core oligosaccharides were purified by gel filtration on BioGel P-10 of the water soluble fraction obtained after mild acid hydrolysis of E. coli J5 lipopolysaccharide and further purified on a BioGel P-2 column. The results of methylation analysis of dephosphorylated oligosaccharides indicated the presence of five sugar residues: terminal Glc, 3-substituted heptose Hep, terminal GlcN, 7-substituted Hep and 3,7-substituted heptose. All of the 1 H and 13 C NMR spectra of the isolated core oligosaccharides contained main signals for five anomeric protons and carbons, and in addition a 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) spin system confirming hexasaccharide structures (not shown). The 31 P NMR spectra indicated heterogeneity among the isolated core oligosaccharides. The observed heterogeneity concerned the substitutions of phosphate esters, diphosphomonoesters, diphosphodiesters and ethanolamine. The positive mode FAB mass spectrum of the mixture of core oligosaccharides obtained after mild acid hydrolysis of LPS was similar to the spectrum obtained by Muller-Loennies et al. (1994; (Fig. 1A) The core oligosaccharide fraction was obtained by mild acid hydrolysis of LPS with 1.5% acetic acid. The reaction mixture was centrifuged to separate lipid A and freeze-dried supernatant was fractionated by gel filtration. The spectrum was obtained in the positive mode using glycerol as a matrix. (B) Structure of the core hexasaccharide (M, molecular ion) of LPS E. coli J5 as reported (Muller-Loennies et al., 1994; .
phosphate (PEtn). The ion at m/z 987.9 represented an oligosaccharide composed of four sugar residues -two Hep, one Glc and one Kdo substituted with a phosphate group and an additional 2-aminoethanol phosphate.
The molecular ions at m/z 1045.0 and 1275.0 (Fig. 1B) corresponded to the glycoforms additionally substituted with a glycine residue as indicated by the mass difference of 57 Da in comparison with the ions at m/z 987.9 and 1218.04, respectively. Similar results were also obtained by MALDI-TOF mass spectrometry. Structural data confirmed the known structure of the core oligosaccharide isolated from E. coli J5 LPS and its heterogeneity that is a result of differences in the primary structure of the carbohydrate backbone and nonstoichiometric substitutions by phosphate residues and PEtn. The presence of glycine in the core region of LPS was observed previously (Li et al., 2001; Niedziela et al., 2002) and it contributes to the overall heterogeneity of the core oligosaccharides.
The E. coli J5 core oligosaccharide-tetanus toxoid conjugate
The core oligosaccharide was selectively oxidised in the Hep-Kdo region to achieve, on average, a single aldehyde group per molecule. The modified core oligosaccharide was used to obtain a covalent conjugate with tetanus toxoid using reductive amination. The calculated molar ratio of the core oligosaccharide to tetanus toxoid was 9:1.
The anti-conjugate sera
The conjugate and killed E. coli J5 bacteria were used to immunise rabbits in order to obtain anti-LPS antibodies. The antibody level in the immune sera was determined in a quantitative microprecipitin test with homologous lipopolysaccharide. E. coli J5 LPS precipitated in the equivalent point 1.6 mg of Ab ml -1 of anti-conjugate serum and 0.7 mg of Ab ml -1 of antiserum against whole bacterial cells. The conjugate of core oligosaccharide of E. coli J5 LPS was a strong immunogen yielding a high level of anti-OS core antibodies.
ELISA assay
The reaction of both sera with lipopolysaccharides isolated from rough and smooth strains of various bacteria were tested by ELISA. The reactions of the antisera with rough E. coli J5, R1, R2, R3, R4 and Salmonella Ra, Rb 1 , Rb 2 , Rc, Rd 1 , Rd 2 , Re lipopolysaccharides are shown on Fig. 2 . The absorbance at 405 nm obtained with antisera 800-fold, 3 200-fold and 25 600-fold diluted Vol. 49 Serological specificity of antibodies directed against E. coli J5 endotoxin 727 Wells were coated using 10 mg/ml solutions of lipooligosaccharides. Casein (2%) was used to block the surface of the plate and the wells were filled with serial two-fold dilutions of the sera (initial dilution: 1:100). Goat anti-rabbit IgG conjugated with alkaline phosphatase as a second antibody and p-nitrophenylphosphate as substrate were used for colour development. The figure shows A 405 values for (n) 800-fold, (n) 3200-fold, (o) 25 600-fold serum dilutions. Data represent the means of three replicates. Standard deviations did not exceed 5% and is not shown.
were compared. Both sera reacted strongly with homologous LPS of E. coli J5 and Salmonella Rc, but the cross-reaction profiles were different for each serum. Lipooligosaccharide of Salmonella Rd 2 reacted strongly with the serum against E. coli J5. The anti-endotoxin serum raised against the core oligosaccharidetetanus toxoid conjugate showed broader specificity. This serum also reacted strongly at high concentration with LPS of E. coli representing R2 an R4 core type. Weak reactions were observed for the same LPSs with the anti-endotoxin serum obtained against E. coli J5. The strong reaction of the anti-E. coli J5 serum with LPS possessing Rd 2 core structure and even the Re type, suggested that deep core epitopes exposed on E. coli J5 bacterial cells are responsible for the induction of specific antibodies that are able to react with the Kdo-heptose region of LPS. The E. coli J5 core oligosaccharide present in the conjugate contained only one Kdo residue at the reducing end and was linked to the protein through a modified Kdo-heptose region. Such an immunogen exposes mainly epitopes of the terminal hexose region and induces antibodies against Rc and complete core structures. Lipopolysaccharides isolated from various bacterial strains were used in ELISA to determine the ability of both antisera described above to recognise core epitopes in the structure of LPS of smooth bacteria (Fig. 3) . LPSs of E. coli, P. shigelloides, Klebsiella pneumoniae, Citrobacter freundii, S. typhimurium, Hafnia alvei, Shigella sonnei Ph I and B. pertussis presenting different types of core oligosaccharides were used in ELISA. Both antisera showed similar specificity in the reaction with most of the lipopolysaccharides isolated from smooth and rough bacterial strains representing identical (E. coli O39, O64, S. sonnei Phase I and II, S. flexneri 2b) or related (E. coli O14, O100, H. alvei PCM 31 and 1207) inner core structure. The less distinct reactions with endotoxins of the antibacterial serum in comparison to the anti-conjugate serum were also found in this experiment.
The strongest reactions of both sera were observed with LPS of E. coli O14, O100, S. flexneri 2b and H. alvei 1207. The anti-conjugate serum showed additionally a distinct reaction with LPS of B. pertussis 186. In contrast to earlier studies (Lugowski et al., 1996a) this antiserum reacted strongly even at low The symbols (*), (**) and (***) represent R1, R2 and R3 core types of LPS, respectively. The figure shows A 405 values for (¢) 800-fold, ( ) 3200-fold, (¢) 25600-fold serum dilutions. Data represent the means of three replicates. Standard deviation did not exceed 5% and is not shown. Assay conditions as in Fig. 2. concentration with E. coli O111 LPS. The antiserum directed against E. coli J5, in contrast to the anti-conjugate serum, reacted distinctly with LPS of P. shigelloides O54, C. freundi O16 and S. sonnei Ph I. Antibodies present in this serum did not recognize epitopes in the LPS of E. coli O111:B4. These results are in agreement with published data (Sakulramrung & Domingue, 1985; Appelmelk et al., 1993) .
Immunoblotting
In order to explain which region of lipopolysaccharides is involved in the reaction with specific sera the reactivity of the anti-conjugate and anti-E. coli J5 serum with lipopolysaccharides of various strains of smooth bacteria was compared in immunoblotting experiments. Lipopolysaccharides were separated by SDS/PAGE and transblotted from the gel onto nitrocellulose. All of the LPSs of smooth strains showed a high molecular mass ladder-like pattern of bands in SDS/PAGE analysis (Fig. 4A) .
All the observed reactions with the anti-conjugate serum concerned mainly the fast migrating LPS fractions non-substituted with O-specific chains. Antibodies against OS J5-TT conjugate reacted with LPSs possessing identical (E. coli O1, O18, O64, O111, S. sonnei Phase I) and related (E. coli O10, O100, H. alvei PCM 31 and 1207, B. pertussis 186 and 606) inner core oligosaccharide. The lack of structural similarity between core oligosaccharide of P. shigelloides CNCTC 113/92 and E. coli J5 was responsible for the absence of reactions of that LPS with anti-conjugate serum. Both sera reacted strongly with core regions of LPS of E. coli O100, H. alvei 1207 and 31 ( Fig. 4B and C) . Lipopolysaccharides showing strong reactions in ELISA only with the anti-E. coli J5 serum, reacted in immunoblotting in the regions of slow migrating fractions. The immunoblotting pattern suggested that slight protein contaminants present in some LPS samples were involved in the observed reactions. LPS fractions obtained during phenol/water extraction contain only traces of proteins not detectable by standard analytical procedures such as SDS/PAGE silver-staining method, UV spectrophotometric assay and MALDI-TOF mass spectrometry. LPS of C. freundii was the only one that also reacted with the anti-E. coli J5 serum in the region of fast migrating fractions.
Flow cytometry (FACS)
The ability of the sera examined to recognise core oligosaccharide epitopes of LPS on the surface of live bacteria were observed using Vol. 49 Serological specificity of antibodies directed against E. coli J5 endotoxin 729 LPSs were separated by SDS/PAGE. Suspensions (1 mg ml -1 ) were mixed with sample buffer and 8 ml portions of LPSs were applied to a gel. Electrophoresis was performed in a 15% acrylamide slab gel. LPSs were detected by silver staining or were analysed by blotting with antibodies directed against anti-OS J5-TT conjugate (200-fold diluted).
FACS analysis (Fig. 5) . Three smooth strains were chosen for the experiment: E. coli O39, O100 and O111 representing LPS of the R1, R2 and R3 core types, respectively. The percentage of bacteria exhibiting fluorescence above background level was in excess of 95% for all tested strains and the ability of both sera to bind to bacterial cells was similar. The highest intensity of fluorescence was observed for E. coli O100. The similar reactivity of the anti E. coli J5 serum, containing lower level of anti-LPS antibodies than present in the anti-conjugate serum, is probably caused by the presence of antibodies against other bacterial surface antigens. This, being in agreement with earlier studies, suggests that antibodies directed against outer membrane proteins can play important role in the cross-reactivity of the anti-E. coli J5 serum.
ELISA inhibition assay
Core oligosaccharides of various core types were isolated from E. coli and Salmonella lipopolysaccharides (Fig. 6) . The inhibitory ac- Bacteria were suspended in PBS to an absorbance of 0.6 at 600 nm (4´10 8 cfu ml -1 ) and mixed with antiserum. All antisera were 100-fold diluted. Non-immune sera were employed as negative controls. The symbols (*), (**) and (***) stand for R1, R2 and R3 core types of LPS, respectively. The antiserum (100 ml) at a concentration twice as high as that giving A 405 in the range 0.8-1.1 was mixed with 100 ml of serial two-fold dilutions of inhibitor and transferred into wells coated with E. coli J5 LPS (10 mg/ml, 100 ml). The figure shows the results for concentrations of inhibitors: (n) 200 mg ml -1 , (n) 50 mg ml -1 , . The oligosaccharides representing E. coli R1, R2, R3, R4, Salmonella Ra and H. alvei core types showed similar activity, i.e. they inhibited the binding of the anti-conjugate serum to E. coli J5 LPS. The inhibition for these oligosaccharides was in the range of 15-60% for the concentrations 10-200 mg ml -1
. The inhibitory activity of Rd core type oligosaccharides was significantly lower. These data suggested that immunisation with the OS J5-TT conjugate did not stimulate rabbits to produce antibodies directed against the heptose region of LPS which was probably not properly exposed in this immunogen.
Inhibition of cytokines and NO induction
LPS of E. coli O100 that showed the most distinct reactions with both sera in serological tests was used to stimulate IL-6, TNFa and NO production by the macrophage-like cell line J-774A.1. The anti-conjugate OS J5-TT and anti-E. coli J5 sera were used to inhibit this stimulation. The results are shown in Fig. 7 . There were no inhibitory effects of the sera examined in comparison with non-immune serum.
It was shown in numerous previous studies (Dunn & Ferguson, 1982; Bhattacharjee et al., 1994; Hogan et al., 1999; Cross et al., 2001 ) that anti-rough mutant E. coli J5 serum containing anti-LPS antibodies protected against challenge with heterologous Gramnegative bacteria or smooth LPS. We expected that anti-OS J5-TT serum possessing higher level of anti-J5 LPS core oligosaccharide antibodies than anti-E. coli J5 serum would show a better protective activity. Instead, we found that both sera were inactive even if the lipopolysaccharide of E. coli O100 was chosen for the challenge. Our earlier studies showed that antiserum obtained against a conjugate of the core oligosaccharide of LPS E. coli R1 with tetanus toxoid (OS R1-TT) attenuated the release of LPS-induced TNFa in vitro as well as in vivo (Lugowski et al., 1996b) . Vol. 49 Serological specificity of antibodies directed against E. coli J5 endotoxin Murine macrophage cell line J774A.1 (1´10 6 cells/ well) was stimulated with 10 ng of LPS. Supernatants were collected after 4 h, 24 h and 48 h for TNFa, IL-6 and NO determination, respectively. TNFa concentration in the supernatants was determined in the cytotoxic assay using WEHI 164.13 bioassay. IL-6 activity was determined using the OptEIA TM kit. Total nitrite (NO 2 -) concentration in the supernatants was determined by the Griess reaction in 100 ml of the test samples. Nitrate was reduced by nitrate reductase. Lipooligosaccharide isolated from E. coli R1 possess complete structure of core OS containing both hexose and heptose regions. Antibodies against OS R1-TT serum recognise the complete core region present in LPSs of smooth bacterial strains. E. coli J5 is a rough mutant possessing non-complete core oligosaccharide of Rc type. This structure is an inner part of the complete core and is substituted with the sugars of the hexose region in the LPS of smooth bacterial strains. It may be assumed that antibodies directed against sugars present at the non-reducing end of complete core structure are responsible for the protective activity of the anti-conjugate serum. Antibodies of such specificity are not present in anti-OS J5-TT serum. This is in agreement with some earlier suggestions of other authors (Appelmelk et al., 1993; Appelmelk et al., 1986; Evans et al., 1992) that the protective effects of anti-E. coli J5 serum were caused by the presence of bacterial revertants with complete R3 core type in the vaccine. The strain of E. coli J5 used in our experiments possesses only non-complete core region in LPS, which was confirmed in the structural analysis of isolated core oligosaccharide.
